Genetic Toxicology Testing Market Size Worth $3.57 Billion By 2030

Genetic Toxicology Testing Market Growth & Trends

The global genetic toxicology testing market size is expected to reach USD 3.57 billion by 2030, according to a new report by Grand View Research, Inc. The market is anticipated to expand at a CAGR of 12.7% from 2022 to 2030. The rising usage of personalized medicines, combined with the development of cell and gene therapy across the globe is enhancing the demand for genotoxicity. For instance, the U.S. FDA has designed guidance documents for the manufacturers of cell and gene therapy. According to the guidance, information on the identification of toxicities and physiologic parameters in preclinical studies can assist in guiding clinical monitoring for the investigational product.

Increasing implementation of pharmacogenomics to support personalized medicine usage and reduced risk of adverse drug toxicity is considered to have a significant impact on the growth of the industry. Moreover, organizations, such as the Dutch Pharmacogenetics Working Group (DPWG), Clinical Pharmacogenetics Implementation Consortium (CPIC), the French National Network of Pharmacogenetics, and the Canadian Pharmacogenomics Network for Drug Safety (CPNDS), have issued clinical guidelines with a primary focus on the pharmacogenomics testing interpretation and recommendation on therapeutic specific drug-gene pairs.

Similarly, the market players are indulging in various strategies to expand their footprint in multiple segments. For instance, in November 2021, Labcorp announced the acquisition of Toxikon, a Contract Research Organization (CRO) with offerings in nonclinical testing services. Through this acquisition, Labcorp is anticipated to strengthen its toxicology business and Toxikon’s location enables Labcorp to engage with known biotech and pharmaceutical companies in the region for non-clinical work.

The COVID-19 pandemic is anticipated to have a neutral impact on the genetic toxicology testing market growth. Numerous researchers employed genotoxic to assess the effects of drugs against the COVID-19 virus. For instance, in September 2020, a team of researchers evaluated the impact of Chloroquine (CQ) and Hydroxychloroquine (HCQ) as prophylactic drugs against the virus. The genetic toxicology of various drugs and chemicals was assessed. Such studies using genetic toxicology testing as a tool of assessment are anticipated to support stable growth during the peak of COVID-19.

The rising demand for novel food and its imports is expected to be a contributor to market growth. Charles River Laboratories is one of the major players offering toxicology assessments on novel foods. They offer novel food analysis including genotoxicity, which consist of in vivo micronucleus test, Ames study, In Vitro Mammalian Cell Micronucleus, and in the vivo comet assay. Similarly, in January 2021, EFSA published its evaluation of insect-derived food. It is the first kind of assessment conducted by the institution on the insect product as a novel food. Every year, EFSA receives a large number of applications, consisting of herbal products based on algae foods, plants, and non-indigenous fruits.

On the other hand, the ability to retrieve information through genetic toxicology is limited. According to the Pathology Tests Explained organization, genetic tests offer information regarding the specific diseases/gene that is being tested. It does not cover information about other genetic diseases that might be present but have not been tested. Similarly, it cannot identify all the variations of genes that cause the diseases, and also it does not showcase the severity of the diseases. Hence, these limitations are anticipated to hamper the growth of the genetic toxicology industry.

 Request a free sample copy or view report summary: Genetic Toxicology Testing Market Report

Genetic Toxicology Testing Market Report Highlights

• By type, the in vitro is expected to be the fastest growing segment with the largest share of the Genetic Toxicology Testing Market in 2021. Owing to the rising requirement by regulatory agencies for genotoxicity in the food industry

• By application, the pharmaceutical & biotechnology segment is estimated to become a major market contributor. This is attributed to an increase in the development of cell and gene therapy, coupled with increasing use of pharmacogenomics and personalized medicines

• The Asia Pacific region is projected to grow substantially over the forecasted period owing to the increasing imports of novel food and tightening test regulations for the same, especially in Australia

• By product, the service segment captured a significant proportion of the share in 2021, owing to the increasing demand by pharmaceutical and biotechnology companies for nonclinical works. Also, increasing strategic initiatives by contract research organizations is a major growth determinant

• North America was a major regional market for genetic toxicology in 2021 owing to the availability of efficient players in the region to match the demand by pharma and biotech companies. The increasing R&D in personalized medicines is also a significant factor

• Some of the main market players include Thermo Fisher Scientific, Inc.; Charles River Laboratories International; Laboratory Corp of America Holdings; and Eurofins Scientific

Genetic Toxicology Testing Market Segmentation

Grand View Research has segmented the global genetic toxicology testing market based on type, product, application, and region:

Genetic Toxicology Testing Type Outlook (Revenue, USD Million, 2018 - 2030)

• In Vitro

• In Vivo

Genetic Toxicology Testing Product Outlook (Revenue, USD Million, 2018 - 2030)

• Reagents & Consumables

• Assays

• Services

Genetic Toxicology Testing Application Outlook (Revenue, USD Million, 2018 - 2030)

• Pharmaceutical & Biotechnology

• Food Industry

• Cosmetics Industry

• Other

Genetic Toxicology Testing Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • U.K.

  • Germany

  • France

  • Italy

  • Spain

• Asia Pacific

  • Japan

  • China

  • India

  • South Korea

  • Australia

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

List of Key Players of the Genetic Toxicology Testing Market

• Thermo Fisher Scientific, Inc.

• Charles River Laboratories International

• Laboratory Corp of America Holdings

• Eurofins Scientific

• Jubilant Life Sciences Limited

• Syngene International Limited

• Gentronix Ltd.

• Inotiv Inc.

• Creative Bioarray

• MB Research Laboratories